COMMUNIQUÉS West-GlobeNewswire

Quotient Limited to Participate in the Raymond James Life Sciences and MedTech Conference
05/06/2019
JERSEY, Channel Islands, June 05, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Chris Lindop, will present [...]
Ceapro Presents Positive Results from Avenanthramides Study at the 2019 American Society of Sports Medicine Meeting
05/06/2019
- Data demonstrated that oat avenanthramides supplementation could inhibit molecules involved in the exercise induced inflammation process EDMONTON, Alberta, June 05, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“ [...]
Dermavant Sciences Announces First Patient Dosed in PSOARING, its Pivotal Phase 3 Clinical Program for Tapinarof for the Topical Treatment of Plaque Psoriasis
05/06/2019
Top-line data is anticipated in the first half of 2020 If PSOARING trials are successful, a New Drug Application (NDA) filing with the U.S. Food and Drug Administration (FDA) is anticipated in 2021 BASEL, Switzerland [...]
Rubius Therapeutics Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs
05/06/2019
First U.S. Composition of Matter Patent Issued for Genetically Engineered Red Cell CAMBRIDGE, Mass., June 05, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company [...]
HempAmericana Announces New Agreement to Become Principal Supplier for Florida-based CBD Brand
05/06/2019
NEW YORK, June 05, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging leader in the CBD products market, is excited to announce that the Company [...]
Gritstone Oncology to Present at Two Upcoming Investor Conferences in June
05/06/2019
EMERYVILLE, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]
Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs
05/06/2019
GAITHERSBURG, Md., June 05, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biotechnology company, today announced that it has received additional patent protection for its HepTcell and ALT-702 [...]
Sproutly Submits Amendment for Flower Sales License
05/06/2019
N O T FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES VANCOUVER, British Columbia, June 05, 2019 (GLOBE NEWSWIRE) -- Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“ Sproutly " or the “ Company [...]
Avricore Health announces private placement
05/06/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH US NEWSWIRE SERVICES VANCOUVER, British Columbia, June 05, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company [...]
Evolus Accelerates Next Phase of U.S. Launch of Jeuveau™ with ‘#NEWTOX NOW’ Consumer Conversion Program
05/06/2019
NEWPORT BEACH, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today announced the launch of the ‘#NEWTOX NOW’ consumer conversion program following the rapid adoption of the company’s Jeuveau™ [...]
Centrexion Therapeutics Announces Completion of Patient Enrollment in Pivotal Clinical Trial of Repeat Doses of CNTX-4975 in Patients with Moderate to Severe Osteoarthritis Knee Pain
05/06/2019
BOSTON, June 05, 2019 (GLOBE NEWSWIRE) -- Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain, today announced completion of [...]
OrthoPediatrics Announces Acquisition of Vilex and Novel External Fixation Technology
05/06/2019
The Company to host conference call today at 8:30am ET WARSAW, Ind., June 05, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of [...]
Neuronetics to Present at the JMP Life Sciences Conference
05/06/2019
MALVERN, Pa., June 05, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]
ProMIS Neurosciences Presents Lead Program for Alzheimer’s Disease at Prestigious Keystone Symposia Scientific Conference
05/06/2019
Neurodegenerative Diseases: New Insights and Therapeutic Opportunities to advance discussion about therapies for Alzheimer’s disease among world’s leading researchers TORONTO and CAMBRIDGE, Mass., June 05, 2019 (GLOBE [...]
Blueberries Announces Cannabis Sales and Distribution Agreement for German Market
05/06/2019
TORONTO, June 05, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a leading Latin American licensed producer of medicinal cannabis and [...]
Media Advisory/TODAY: Montreal’s Four Leading Pediatric Institutions to Announce Largest Collaboration in Canadian History to Help Children with Musculoskeletal Disorders
05/06/2019
MONTREAL, June 05, 2019 (GLOBE NEWSWIRE) -- The largest collaboration of its kind in Canadian history will be announced today, June 5, 2019, by the foundations of the CHU Sainte-Justine and its Marie Enfant [...]
Avis aux médias : Les quatre principaux établissements pédiatriques montréalais annonceront AUJOURD’HUI la plus importante collaboration de l’histoire du Canada pour aider les enfants atteints de troubles musculosquelettiques
05/06/2019
MONTRÉAL, 05 juin 2019 (GLOBE NEWSWIRE) -- La plus importante collaboration du genre dans l’histoire du Canada sera annoncée aujourd’hui, le 5 juin 2019, par les fondations du CHU Sainte-Justine et de son Centre de [...]
Helius Medical Technologies, Inc. Announces Addition of Three New PoNS™ Authorized Clinics in Canada
05/06/2019
NEWTOWN, Pa., June 05, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported that three new [...]
Myriad Genetics to Present at the 2019 Goldman Sachs Global Healthcare Conference
05/06/2019
SALT LAKE CITY, June 05, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]

Pages